SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience submits analyst meet intimation

17 Aug 2023 Evaluate
Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that the officials of the Company, Supriya Lifescience will be interacting with Analyst/Institutional Investors on August 21, 2023 via video conference. Further informed that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company’s website www.supriyalifescience.com. This information is submitted pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

641.40 4.50 (0.71%)
15-Apr-2026 12:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1680.05
Dr. Reddys Lab 1217.00
Cipla 1224.45
Zydus Lifesciences 936.75
Lupin 2352.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×